Chinese herbal medicine Dengzhan Shengmai capsule as adjunctive treatment for ischemic stroke: A systematic review and meta-analysis of randomized clinical trials.

CONCLUSION: DZSM capsule appears to improve neurological function, quality of life, and reduce recurrence rate based on conventional therapy for ischemic stroke. DZSM capsule seems generally safe for clinical application. However, the findings of benefit are inconclusive due to generally weak evidence, and further large, rigorous trials are still warranted.
PMID: 29458937 [PubMed - in process]

Source: Complementary Therapies in Medicine - February 1, 2018 Category: Complementary Medicine Authors: Yang XY, Wang LQ, Li JG, Liang N, Wang Y, Liu JP Tags: Complement Ther Med Source Type: research